1. Simple Cancer Stem Cell Markers Predict Neoadjuvant Chemotherapy Resistance of Esophageal Squamous Cell Carcinoma
- Author
-
Kimihiro Yamashita, Junko Mukohyama, Tetsu Nakamura, Gosuke Takiguchi, Kouta Yamada, Kyosuke Agawa, Shingo Kanaji, Mitsugu Fujita, Taro Oshikiri, Yoshihiro Kakeji, Satoshi Suzuki, Masafumi Saito, Hiroshi Hasegawa, Naoki Urakawa, Akihiro Watanabe, Takeru Matsuda, and Akio Nakagawa
- Subjects
Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Esophageal Neoplasms ,medicine.medical_treatment ,Antineoplastic Agents ,Antigens, CD ,Cancer stem cell ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Biopsy ,Biomarkers, Tumor ,medicine ,Humans ,Aged ,Retrospective Studies ,Cisplatin ,Chemotherapy ,biology ,medicine.diagnostic_test ,CD24 ,business.industry ,CD44 ,Retrospective cohort study ,General Medicine ,Esophageal cancer ,medicine.disease ,Neoadjuvant Therapy ,Esophagectomy ,Drug Resistance, Neoplasm ,Neoplastic Stem Cells ,biology.protein ,Female ,Esophageal Squamous Cell Carcinoma ,Fluorouracil ,business ,medicine.drug - Abstract
Background/aim Cancer stem cells (CSCs) contribute to resistance against neoadjuvant chemotherapy (NAC) in esophageal squamous cell carcinoma (ESCC). We conducted a retrospective observational study for the relationship between the expression levels of CSC markers in biopsy specimens prior to 5-fluorouracil plus cisplatin (FP)-NAC and the pathological responses. Patients and methods We included 171 patients with ESCC who underwent the FP-NAC followed by radical resection. Biopsy specimens prior to the FP-NAC were obtained and immunochemically stained for CD44, CD133, and CD24. Results The biopsy specimens of the non-responders had the CD44high/CD24low expression at high levels, which was found as an independent predictor of not only FP-NAC resistance but also poor overall survival by multivariate analyses. Conclusion CD44high/CD24low expression in the biopsy specimens prior to FP-NAC may be a predictor of FP-NAC resistance and poor prognosis of ESCC patients.
- Published
- 2021
- Full Text
- View/download PDF